Discovery of new IRAP inhibitors to improve cognitive functions

June 01, 2016

New Rochelle, June 1, 2016-Researchers have discovered three new inhibitors of insulin-regulated aminopeptidase (IRAP), compounds shown to improve cognitive functions in animal models of human disorders. The new inhibitors are able to block human IRAP at low concentrations with rapid reversibility, as described in a study published in ASSAY and Drug Development Technologies, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the ASSAY and Drug Development Technologies website until July 1, 2016.

In the article "Identification of Drug-Like Inhibitors of Insulin-Regulated Aminopeptidase Through Small Molecule Screening," Karin Engen and coauthors from Uppsala University and Karolinska Institutet (Solna), Sweden, and Vrije Universiteit Brussel, Brussels, Belgium, report on the high throughput screening method they used to test a diverse library of 10,500 compounds for activity against IRAP. The rapid, automated, enzymatic assay led to the identification of 23 active compounds. Rigorous characterization of these actives reduced the number of compounds of particular interest to three, and these served as the starting points for the development of small molecule-based IRAP inhibitors to take into preclinical testing.

"The paper by Engen et al. describes exemplary work successfully executing a carefully planned strategy to identify high-value hits from high-throughput screens," says ASSAY and Drug Development Technologies Editor-in-Chief Andrew D. Napper, PhD, Associate Director, Nemours Center for Childhood Cancer Research, Head - High Throughput Screening/Drug Discovery Laboratory, and Senior Research Scientist, Nemours/A.I. duPont Hospital for Children (Wilmington, DE). "Using high-throughput screening and hit confirmation, the authors identified and efficiently prioritized inhibitors of insulin-regulated aminopeptidase, which hold promise for the improvement of cognitive functions in animal models and advancement into clinical testing."
About the Journal

ASSAY and Drug Development Technologies is an authoritative peer-reviewed journal published 10 times a year online with open access options and in print. Led by Editor-in-Chief Andrew D. Napper, PhD, Associate Director, Nemours Center for Childhood Cancer Research, Head - High Throughput Screening/Drug Discovery Laboratory, and Senior Research Scientist, Nemours/A.I. duPont Hospital for Children (Wilmington, DE), the Journal provides early-stage screening techniques and tools that enable identification and optimization of novel targets and lead compounds for new drug development. Complete tables of content and a sample issue may be viewed on the ASSAY and Drug Development Technologies website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Applied In Vitro Toxicology, OMICS: A Journal of Integrative Biology, and Genetic Testing and Molecular Biomarkers. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc./Genetic Engineering News

Related Cognitive Functions Articles from Brightsurf:

How organ functions were shaped over the course of evolution
A large-scale study conducted by molecular biologists from Heidelberg University has yielded groundbreaking new insights into the evolution and regulation of gene expression in mammalian organs.

From virtual to reality! Virtual training improves physical and cognitive functions
Researchers at the Smart-Aging Research Center (IDAC) at Tohoku University have developed an innovative training protocol that, utilizing immersive virtual reality (IVR), leads to real physical and cognitive benefits.

Immune functions traded in for reproductive success
Researchers at the MPI of Immunobiology and Epigenetics in Freiburg, Germany, and the University of Washington in Seattle, USA, for the first time, investigate the phenomenon of sexual parasitism in deep-sea anglerfish.

'Seeing' and 'manipulating' functions of living cells
Toyohashi University of Technology has given greater functionalities to atomic force microscopy (AFM).

Brain-like functions emerging in a metallic nanowire network
An international joint research team led by NIMS succeeded in fabricating a neuromorphic network composed of numerous metallic nanowires.

Social, executive brain functions crucial for communication
Impairments in social and executive brain functions hinder effective communication, according to research in patients with dementia recently published in eNeuro.

Single-electrode material streamlines functions into a tiny chip
Ruthenium oxide is used to integrate energy-storing microsupercapacitors and thin-film electronics at the transistor level.

IDIBELL-researchers negatively correlate a neuropeptide with executive functions
Researchers from IDIBELL and the group of Eating Disorders, of the HUB, led by Dr.

Scientists restore some functions in a pig's brain hours after death
Circulation and cellular activity were restored in a pig's brain four hours after its death, a finding that challenges long-held assumptions about the timing and irreversible nature of the cessation of some brain functions after death, Yale scientists report April 18 in the journal Nature.

Research underscores value of cognitive training for adults with mild cognitive impairment
Researchers at the Center for BrainHealth®, part of The University of Texas at Dallas, combined two non-pharmacological interventions for adults with Mild Cognitive Impairment (MCI): eight sessions of Strategic Memory Advanced Reasoning Training (SMART), a cognitive training program shown to improve reasoning and ability to extract bottom-line messages from complex information; and Transcranial Direct Current Stimulation (tDCS) over the left frontal region, associated with cognitive control and memory recovery success in people with Alzheimer's.

Read More: Cognitive Functions News and Cognitive Functions Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to